Company · CIK 0000728387 · SIC 2834 — Pharmaceutical Preparations · NYSE
Perspective Therapeutics, Inc. · CATX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 SForm 4 → | Sep 8, 4:51 pm EDT | Lantheus Alpha Therapy, LLC +110% Owner | 247,932 | $3.13 | $776,947 | 11,273,364 | −2.15% | |
| Sep 2, 2026 SForm 4 → | Sep 4, 5:00 pm EDT | Lantheus Alpha Therapy, LLC +110% Owner | 42,129 | $3.11 | $131,219 | 11,521,296 | −0.36% | |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:54 pm EDT | Lantheus Holdings, Inc.10% Owner | 35,769 | $3.12 | $111,574 | 11,563,425 | −0.31% | |
| Aug 31, 2026 SForm 4 → | Sep 4, 4:58 pm EDT | Lantheus Alpha Therapy, LLC10% Owner | 113,914 | $3.14 | $357,184 | 11,563,425 | −0.98% | late |
| Aug 31, 2026 SForm 4 → | Sep 2, 4:36 pm EDT | Lantheus Holdings, Inc.10% Owner | 78,145 | $3.14 | $245,610 | 11,599,194 | −0.67% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.